Infection with respiratory syncytial virus and water-soluble components of cigarette smoke alter production of tumour necrosis factor α and nitric oxide by human blood monocytes

FEMS Immunology and Medical Microbiology

Volumn 24, Issue 4, 1999, Pages 387-394

  Raza, Muhammad W ^a   Essery, Steve D ^a   Weir, Donald M ^a   Ogilvie, Marie M ^a   Elton, Robert A ^a   Blackwell, C Caroline ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cigarette smoke; Inflammation; Monocyte; Respiratory syncytial virus; Tumor necrosis factor

Indexed keywords

CIGARETTE SMOKE; COTININE; GAMMA INTERFERON; NICOTINE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYSTEM;

ANIMALS; CELL LINE; HUMANS; MICE; MONOCYTES; NITRIC OXIDE; PLANTS, TOXIC; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; SMOKE; TOBACCO; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA; WATER;

EID: 0032967944     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00019-X     Document Type: Article

References (36)

1. Silverman E.K., Speizer F.E. Risk factors for the development of chronic obstructive pulmonary disease. Med. Clin. N. Am. 80:1996;501-522.
2. Monto A.S. Epidemiology of respiratory viruses in persons with or without asthma and COPD. Am. J. Respir. Crit. Care Med. 151:1995;1653-1657.
3. Barnes P.J., Belvisi M.G. Nitric oxide and lung disease. Thorax. 48:1993;1034-1043.
4. de Godoy I., Donahoe M., Calhoun W.J., Mancino J., Rogers R.M. Elevated TNF-α production by peripheral blood monocytes of weight-losing COPD patients. Am. J. Respir. Crit. Care Med. 153:1996;633-637.
5. Keatings V.M., Collins P.D., Scott D.M., Barnes P.J. Differences in interleukin-8 and tumour necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am. J. Res. Crit. Care Med. 153:1996;530-534.
6. Panuska J.R., Merolla R., Robert N.A., Hoffmann S.P., Tsivitse P., Cirino N.M., Siverman R.H., Rankin J.A. Respiratory syncytial virus induces interleukin-10 by human alveolar macrophage. Suppression of early cytokine production and implications for incomplete immunity. J. Clin. Invest. 96:1995;2445-2453.
7. Franke G., Freihorst J., Steinmuller C., Verhagen W., Hockertz S., Lohman-Mathes M.L. Interaction of alveolar macrophages and respiratory syncytial virus. J. Immunol. Methods. 174:1994;173-184.
8. Dietzschold B. The role of nitric oxide in the pathogenesis of virus-induced encephalopathies. Curr. Top. Microbiol. Immunol. 95:1995;51-56.
9. Tappia P.S., Troughton K., Langley-Evans S., Grimble R.F. Cigarette smoking influences cytokine production and antioxidant defences. Clin. Sci. 88:1995;485-489.
10. Sauty A., Mauel J., Philippeaux M., Leuenberger P. Cytostatic activity of alveolar macrophages from smokers and non-smokers, role of interleukin-1 beta, interleukin-6, and tumour necrosis factor-α Am. J. Res. Cell Mol. Biol. 11:1994;631-637.
11. Kharitonov S.A., Robbin R.A., Yates D., Barnes P.J. Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am. J. Respir. Crit. Care Med. 152:1995;609-612.
12. Alving K., Fornhem C., Lundberg J.M. Pulmonary effects of endogenous and exogenous nitric oxide in the pig, relation to cigarette smoke inhalation. Br. J. Pharm. 110:1993;739-746.
13. Becker S., Soukup J., Yankaskas J.R. Respiratory syncytial virus infection of human primary nasal and bronchial epithelial cell cultures and broncho- alveolar macrophages. Am. J. Res. Cell Mol. Biol. 6:1992;369-374.
14. Adair B.M., Bradford H.E., Mackie D.P., McNulty M.S. Effect of macrophages and in vitro infection with parainfluenza type 3 and respiratory syncytial viruses on the mitogenic response of bovine lymphocytes. Am. J. Vet. Res. 53:1992;225-229.
15. Roberts N.J. Jr., Hiscott J., Signs D.T. The limited role of the human interferon system response to respiratory syncytial virus challenges, analysis and comparison to influenza virus challenge. Microb. Pathogen. 12:1992;409-414.
16. Berkman G.E., Park S.B., Wringhton S.A., Gashman J.R. In vitro-in vivo correlation of human (S)-nicotine metabolism. Biochem. Pharmacol. 50:1995;565-570.
17. Higashimoto Y., Shimada Y., Fukuchi Y., Ishida K., Shu C., Teramoto S., Sundo E., Matsuese T., Orimo H. Inhibition of mouse alveolar macrophage production of tumour necrosis factor-α by acute in vivo and in vitro exposure to tobacco smoke. Respiration. 59:1992;77-80.
18. Raza M.W., Ogilvie M.M., Blackwell C.C., Stewart J., Elton R.A., Weir D.M. Effect of respiratory syncytial virus infection on binding of Neisseria meningitidis and Haemophilus influenzae type b to human epithelial cell line (HEp-2 cells). Epidemiol. Infect. 110:1993;339-347.
19. Delahooke D.M., Barclay G.R., Poxton I.R. Tumour necrosis factor induction by an aqueous phenol-extracted lipopolysaccharide complex from Bacteroides species. Infect. Immun. 63:1995;840-846.
20. Fischer H., Dohlsten M., Anderson U.L.F., Hedland G., Ericsson P., Hanson J., Sjogren H.O. Production of TNF-α and TNF-β by staphylococcal enterotoxin A activated human T cells. J. Immunol. 144:1990;4663-4669.
21. Zhang X., Alley E.W., Russel S.W., Morrison D.C. Necessity and sufficiency of beta interferon for nitric oxide production in mouse peritoneal macrophages. Infect. Immun. 62:1994;33-40.
22. Geng Y., Savage S.M., Johnson L.T., Seagrave J.C., Sopori M.L. Effect of nicotine on the human responses. 1. Chronic exposure to nicotine impairs antigen receptor-mediated signal transduction in lymphocytes. Toxicol. Appl. Pharmacol. 135:1995;268-275.
23. Hall C.B. Prevention of infections with respiratory syncytial virus, the hope and hurdles ahead. Rev. Infect. Dis. 2:1980;384-392.
24. Hall C.B., Walsh E.E., Long C.E., Schnable K.C. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 163:1991;693-698.
25. Philit F., Etienne J., Calvet A., Mornex J.F., Trillet V., Aymard M., Brune J., Cordier J.F. Infectious agents associated with exacerbations of chronic obstructive bronchopneumopathies and asthma attacks (Abstract). Rev. Mal. Respir. 9:1992;191-196.
26. El-Ahmer, O.R., MacKenzie, D.A.C., James, V.S., Blackwell, C.C., Raza, M.W., Saadi, A.T. and Weir, D.M. (1994) Exposure to cigarette smoke and colonisation of Neisseria species. In: Neisseria 94 (Evans, J.S., Yost, S.E., Maiden, M.C.J. and Feavers, I.M., Eds.), pp. 281-283. England.
27. Saadi A.T., Blackwell C.C., Essery S.D., Raza M.W., Weir D.M., Elton R.A., Busuttil A., Keeling J.W. Development and environmental factors that enhance binding of Bordetella pertussis to human epithelial cells in relation to sudden infant death syndrome (SIDS). FEMS Immunol. Med. Microbiol. 16:1996;81-89.
28. Babiuk L.A., Lawman M.G., Ohmann H.B. Viral-bacterial synergistic interaction in respiratory disease. Adv. Viral Res. 35:1988;219-249.
29. Philips B., Marshall M.E., Brown S., Thompson J.S. Effect of smoking on human natural killer cell activity. Cancer. 56:1985;2789-2792.
30. Westendorp R.G.J., Langerman J.A.M., Huizinga T.W.J., Elouali A.H., Verwiej C.L. Genetic influence on cytokine production and fatal meningococcal disease. Lancet. 349:1997;170-173.
31. Midulla F., Huang W.T., Gilbert I.A., Cirino N.M., McFadden E.R., Panuska J.R. Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages. Am. Rev. Respir. Dis. 140:1989;771-777.
32. Cirino N.M., Panuska J.R., Villani A., Teraf H., Robert N.A., Merolla R., Tsiritse P., Gilbert I.A. Restricted replication of respiratory syncytial virus in human alveolar macrophages. J. Gen. Virol. 74:1993;1527-1537.
33. Nussler A.K., Billiar T.R. Inflammation, immunoregulation and inducible nitric oxide synthase. J. Leukocyte Biol. 54:1993;171-178.
34. Mautino G., Eugene N., Ghanez P., Vignola A.M., Kolb J.P., Bouquet J., Dugas B. Heterogenous spontaneous and interleukin-4-induced nitric oxide production by human monocytes. J. Leukocyte Biol. 56:1994;15-20.
35. Yoshizumi M., Perella M.A., Burnett J.C. Jr., Lee M.E. Tumour necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half life. Circ. Res. 73:1993;205-209.
36. Sodhi A., Basu S. Role of human blood monocytes in upregulation of lymphokine (interleukin-2)-activated killer cell activity with cisplatin and FK-565. Nat. Immun. 11:1992;105-116.